Program overview: Big Data and AI: Can Medicine Do the Doable?

- presentation titles are partially preliminary-

Print version of the program

 

 

 

9:00 - 9:50

Welcome & Intro to DigiMed Bayern & Keynote

9:00-9:05

Welcome at the Gene CenterProf. Dr. Karl-Peter Hopfner, Director Gene Center Munich

 

Welcome & Philosophy of DigiMed

Prof. Dr. Heribert Schunkert, Clinical Director, German Heart Centre Munich

 

Welcome Video Message

Klaus Holetschek, State Minister, Bavarian Minister of Health and Care

 

Keynote

 

Lisbeth Nielsen, Director General, Danish Health Data Authority

9:50-11:30

Session A:

P4 Medicine examples from DigiMed Bayern

Moderator:

Prof. Dr. Heribert Schunkert, German Heart Centre Munich

 

Personalised medicine in coronary artery disease is sustainably improved by combining clinical and OMICs data

Dr. Moritz von Scheidt, German Heart Centre Munich

 

Preventive: Early diagnosis and treatment of children with Familial Hypercholesterolemia, the VRONI-study

Dr. Veronika Sanin, German Heart Centre Munich

 

Predictive: Epidemiological studies enhanced with molecular phenotypes

Prof. Dr. Annette Peters, Director of the Institute of Epidemiology, Helmholtz Zentrum Munich and and Principal Investigator, German National Cohort (NAKO)

 

Participatory: HerzFit: Generation of a Health App

Dr. Fabian Starnecker, German Heart Centre Munich & Lara Marie Reimer, Technical University of Munich

 

Heart(s) of the Matter: P4-Medicine from the Perspective of Ethics

Prof. Dr. Reiner Anselm & Dr. Therese Feiler, Ludwig-Maximilians-University, Institut Technik-Theologie-Naturwissenschaften

11:30-12:45

 Lunch & Networking

 

12.45-14.05

Session B:

Infrastructure & Pilot Projects

Moderator:

Dr. Jens Wiehler, BioM Biotech Cluster Development GmbH

 

Bavarian Cloud for Health Research - a collaborative infrastructure for biomedicine

Dr. Christian Mertes, Workflow coordinator German Human Genome-Phenome Archive, Munich Data Science Institute, Technical University of Munich

 

Enabling health data for primary and secondary use in Bavaria and in GAIA-X: Team-X project

Prof. Dr. Björn Eskofier, Friedrich-Alexander-University Erlangen-Nürnberg

 

Secondary data use supported by national infrastructure

Stefan Höcherl, Director Strategy and Standards, gematik GmbH

 

Bavarian State: Our vision of data driven health, care and R&D

Dr. Thomas Huber, Head of Department 1, Bavarian State Ministry of Health and Care

14:05-14:30

 Coffee Break

 

14:30-16:00

Session C:

International Benchmarking

Moderator:

Prof. Dr. Horst Domdey, BioM Biotech Cluster Development GmbH

 

AWS Healthcare: Our view on the German healthcare market and secondary data use in international comparison

Joanna Wardzinski, Health Tech Lead & Operations, International, AWS Healthcare

 

The Finnish pathway towards the legislative framework for secondary use of social and health data

Dr. Päivi Sillanaukee, Ambassador for Health and Wellbeing, Ministry for Foreign Affairs of Finland

 

Secondary use of patient data from the perspective of the research-based pharmaceutical industry

 

Dr. Henning Düwert, Senior Counsel Pharmaceutical Law, Verband Forschender Arzneimittelhersteller e.V.

 

Overall discussion with audience & closing remarks

All, Prof. Dr. Horst Domdey and Prof. Dr. Heribert Schunkert

16:00-16:30

 Networking, drinks & fingerfood